Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9896506 Anti-CD79B antibodies and immunoconjugates and methods of use

Patent 9896506 was granted and assigned to Genentech on February, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yvonne Chen0

Andrew Polson0

Bing Zheng0

David Dornan0

Jagath Reddy Junutula0

Kristi Elkins0

Mark Dennis0

Date of Patent

February 20, 2018

0

Patent Application Number

147349570

Date Filed

June 9, 2015

0

Patent Citations Received

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

0

US Patent 11692041 Antibody molecules which bind CD45

0

US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

0

Patent Primary Examiner

Ronald Schwadrom

0

Patent abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals, including immunoconjugates comprising anti-CD79b cysteine-engineered antibody huMA79b.v28, and to methods of using those compositions of matter for the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9896506 Anti-CD79B antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.